Lifevantage Corporation (LFVN)

Currency in USD
4.810
+0.030(+0.63%)
Closed·
4.849+0.039(+0.81%)
·
High dividend Yield
LFVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.6405.000
52 wk Range
3.90011.710
Key Statistics
Prev. Close
4.78
Open
4.78
Day's Range
4.64-5
52 wk Range
3.9-11.71
Volume
136.87K
Average Volume (3m)
44.64K
1-Year Change
-25.7716%
Book Value / Share
2,65
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.500
Upside
+35.14%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Lifevantage Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.500
(+35.14% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Freedom Broker
Buy8.00+66.32%9.00MaintainNov 13, 2026
Lake Street
Hold6.00+24.74%5.00MaintainAug 28, 2026
Lake Street
Hold---DowngradeMay 07, 2026
Lake Street Capital Markets
Buy5.00+3.95%12.00MaintainFeb 05, 2026

Lifevantage Corporation Earnings Call Summary for Q1/2027

  • LifeVantage Q1 FY2027 revenue fell 22% to $37.1M, missing estimates by 10.5%; adjusted EPS of $0.05 missed consensus by 37.5%.
  • Gross margin compressed to 75.4% from 79.5% YoY; SG&A rose to 34.3% of sales amid weaker MindBody GLP-1 System demand and macro headwinds.
  • Company maintains $13.7M cash with zero debt; continues $0.05 quarterly dividend despite posting $0.2M GAAP net loss versus $2.2M profit YoY.
  • No formal guidance issued due to CEO transition; turnaround focuses on Protandim Nrf2 relaunch, new digital platform in Q2 2027, seller tools in Q3.
  • Management expects capex of $3M-$3.5M annually through digital buildout; commission expenses to stabilize at 41-42% range with 20-25% tax rate.
Last Updated: 2026/11/10, 00:12
Read Full Transcript

Earnings

Latest Release
Nov 09, 2026
EPS / Forecast
0,05 / 0,08
Revenue / Forecast
37,1M / 41,45M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0,22
Dividend Yield
4.18%
Industry Median 2.10%
Annualised payout
0.20
Paid quarterly
5-Years Growth
-
Growth Streak

LFVN Income Statement

Compare LFVN to Peers and Sector

Metrics to compare
LFVN
Peers
Sector
Relationship
P/E Ratio
22.7x0.0x10.7x
PEG Ratio
−0.310.030.03
Price/Book
1.9x0.8x1.5x
Price / LTM Sales
0.4x0.8x0.8x
Upside (Analyst Target)
35.1%−4.8%22.4%
Fair Value Upside
Unlock25.3%14.1%Unlock

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Employees
216

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1,21M9,67%5,78M
Other Institutional Investors
6,66M53,18%31,78M
Public Companies & Retail Investors
4,65M37,15%22,20M
Total
12,53M100,00%59,76M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Capital Management Corporation18,42%2 307 48911 007
Sudbury Capital Management, LLC5,98%749 3253 574

FAQ

What Is the Lifevantage (LFVN) Stock Price Today?

The Lifevantage stock price today is 4,810 USD.

What Stock Exchange Does Lifevantage Trade On?

Lifevantage is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Lifevantage?

The stock symbol for Lifevantage is "LFVN."

Does Lifevantage Pay Dividends? What’s The Current Dividend Yield?

The Lifevantage dividend yield is 4,2%%.

What Is the Lifevantage Market Cap?

As of today, Lifevantage market cap is 60,370M USD.

What Is Lifevantage's Earnings Per Share (TTM)?

The Lifevantage EPS (TTM) is 0,22.

When Is the Next Lifevantage Earnings Date?

Lifevantage will release its next earnings report on Feb 02, 2027.

From a Technical Analysis Perspective, Is LFVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lifevantage Stock Split?

Lifevantage has split 2 times.

How Many Employees Does Lifevantage Have?

Lifevantage has 216 employees.

What is the current trading status of Lifevantage (LFVN)?

As of Nov 18, 2026, Lifevantage (LFVN) is trading at a price of 4,810 USD, with a previous close of 4,780 USD. The stock has fluctuated within a day range of 4,640 USD to 5,000 USD, while its 52-week range spans from 3,900 USD to 11,710 USD.

What Is Lifevantage (LFVN) Price Target According to Analysts?

The average 12-month price target for Lifevantage is 6,500 USD, with a high estimate of 8 USD and a low estimate of 5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +35,14% Upside potential.

What Is the LFVN Premarket Price?

LFVN's last pre-market stock price is 4,870 USD. The pre-market share volume is 10,000, and the stock has decreased by 0,090, or 1,880%.

What Is the LFVN After Hours Price?

LFVN's last after hours stock price is 4,849 USD, the stock has decreased by 0,039, or 0,810%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.